Long term holder. Bought in around 1.05 and been holding since. due to attractive dividends and ongoing growth, I don't see any point in selling this.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025